Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Efficacy Testing Market: By Product and Service, By Type, By Application and Region Forecast 2020-2031
Efficacy Testing Market size was valued at US$ 475.0 million in 2024 and is expected to reach US$ 733.3 million by 2031, growing at a significant CAGR of 6.4% from 2025-2031. Efficacy testing is used for determining the efficiency of the product by analyzing a variety of tests such as the stability test, toxicology test, and safety test. In other words, it is a set of trials and procedures in product research and development that determine the product's intended purpose to authorize those substantial claims that appear on the packaging or in advertisements. Efficacy testing has a wide range of applications in numerous sectors such as cosmetics and personal care products pharmaceutical manufacturing, consumer products, and medical devices which boosts the demand for efficacy testing.
Furthermore, stringent regulations for pharmaceutical and cosmetic products proving the safety of the products are further expected to push the growth of the global market for efficacy testing during the forecasted period. During COVID-19 outbreak has increased the demand for institutional and household disinfection to prevent the spread of the disease. The EPA also added several natural disinfectants to its "approved" list for fighting COVID-19. Government bodies announced special financial support toward the development of preventive and curative drugs, the purchase of critical care medical devices, and the fast-track approval of diagnostic tests. Various organizations across the world, such as the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, came together to hasten and strengthen the efforts to fight the COVID-19 pandemic. Post-COVID-19, the demand for surface disinfectants is expected to level up due to the rising awareness about personal hygiene, and with the emergence of new key players in the surface disinfectants market, which in turn, will hike the demand for disinfectant efficacy testing, consequently would expect to expand the efficacy testing market size.
Study Period
2025-2031Base Year
2024CAGR
6.4%Largest Market
Asia-PacificFastest Growing Market
North-America
The efficacy testing market is primarily driven by guidelines for the safety and efficacy of pharmaceutical products, increasing funding from government bodies across the globe for pharmaceutical and biotechnology industries, and increasing investments for research and development actions in these sectors. Moreover, increasing the adoption of the quality-by-design approach has also augmented the demand for efficacy testing. The market is constrained by the antagonistic effects of chemical disinfectants that have toxic properties. Such as, sodium hypochlorite is an effective treatment against blood-borne pathogens but it is highly corrosive and a respiratory irritant, which makes it dangerous for cleaning workers and building residents as it causes damage to many surfaces and is toxic when released into the environment.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 475.0 million |
Market Size in 2031 |
US$ 733.3 million |
Market CAGR |
6.4% |
By Product and Services |
|
By Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
The efficacy testing market size was valued at US$ 475.0 million in 2024 and is expected to reach US$ 733.3 million by 2031, growing at a significant CAGR of 6.4% from 2025-2031.
Key players’ profiles in the market report are Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Microbac Laboratories, Inc. (US), Almac Group (UK)
A rise in the patient population across the globe resulted in increasing regulations for the safety and efficacy of pharmaceutical products and increasing investments and funds from governments worldwide in the pharmaceutical and biotechnology sectors.
1. Executive Summary |
2. Global Efficacy Testing Market Introduction |
2.1. Global Efficacy Testing Market Taxonomy |
2.2. Global Efficacy Testing Market Definitions |
2.2.1. By Product and Service |
2.2.2. By Type |
2.2.3. By Application |
2.2.4. By Region |
3. Global Efficacy Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Efficacy Testing Market Dynamic Factors - Impact Analysis |
3.6. Global Efficacy Testing Market Competition Landscape |
4. Global Efficacy Testing Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Efficacy Testing Market, By Product and Service, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
5.1. Consumables |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Services |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Efficacy Testing Market, By Type, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
6.1. Antimicrobial Efficacy Testing |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Disinfectant Efficacy Testing |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Efficacy Testing Market Forecast, By Application, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
7.1. Pharmaceutical Manufacturing |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Cosmetic |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Personal Care Products |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Efficacy Testing Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
8.1. North America |
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Efficacy Testing Market - Opportunity Analysis Index, By Product and Service, By Type, By Application, and Region, 2024 - 2030 |
9. North America Efficacy Testing Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
9.1. Product and Service Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Consumables |
9.1.2. Services |
9.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Antimicrobial Efficacy Testing |
9.2.2. Disinfectant Efficacy Testing |
9.2.3. Others |
9.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Pharmaceutical Manufacturing |
9.3.2. Cosmetic |
9.3.3. Personal Care Products |
9.3.4. Others |
9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Efficacy Testing Market - Opportunity Analysis Index, By Product and Service, By Type, By Application, and Country, 2024 - 2030 |
9.6. North America Efficacy Testing Market Dynamics Trends |
10. Europe Efficacy Testing Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
10.1. Product and Service Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Consumables |
10.1.2. Services |
10.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Antimicrobial Efficacy Testing |
10.2.2. Disinfectant Efficacy Testing |
10.2.3. Others |
10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Pharmaceutical Manufacturing |
10.3.2. Cosmetic |
10.3.3. Personal Care Products |
10.3.4. Others |
10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Russia |
10.4.7. Rest of Europe |
10.5. Europe Efficacy Testing Market - Opportunity Analysis Index, By Product and Service, By Type, By Application, and Country, 2024 - 2030 |
10.6. Europe Efficacy Testing Market Dynamics Trends |
11. Asia-Pacific Efficacy Testing Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
11.1. Product and Service Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Consumables |
11.1.2. Services |
11.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Antimicrobial Efficacy Testing |
11.2.2. Disinfectant Efficacy Testing |
11.2.3. Others |
11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Pharmaceutical Manufacturing |
11.3.2. Cosmetic |
11.3.3. Personal Care Products |
11.3.4. Others |
11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. Japan |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Efficacy Testing Market - Opportunity Analysis Index, By Product and Service, By Type, By Application, and Country, 2024 - 2030 |
11.6. Asia-Pacific Efficacy Testing Market Dynamics Trends |
12. Latin America Efficacy Testing Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
12.1. Product and Service Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Consumables |
12.1.2. Services |
12.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Antimicrobial Efficacy Testing |
12.2.2. Disinfectant Efficacy Testing |
12.2.3. Others |
12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Pharmaceutical Manufacturing |
12.3.2. Cosmetic |
12.3.3. Personal Care Products |
12.3.4. Others |
12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Efficacy Testing Market - Opportunity Analysis Index, By Product and Service, By Type, By Application, and Country, 2024 - 2030 |
12.6. Latin America Efficacy Testing Market Dynamics Trends |
13. Middle East and Africa Efficacy Testing Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)Â |
13.1. Product and Service Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Consumables |
13.1.2. Services |
13.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Antimicrobial Efficacy Testing |
13.2.2. Disinfectant Efficacy Testing |
13.2.3. Others |
13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Pharmaceutical Manufacturing |
13.3.2. Cosmetic |
13.3.3. Personal Care Products |
13.3.4. Others |
13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Efficacy Testing Market - Opportunity Analysis Index, By Product and Service, By Type, By Application, and Country, 2024 - 2030 |
13.6. MEA Efficacy Testing Market Dynamics Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Charles River Laboratories (US) |
14.2.2. WuXi AppTec (China) |
14.2.3. Eurofins Scientific (Luxembourg) |
14.2.4. SGS (Switzerland) |
14.2.5. Intertek Group (UK) |
14.2.6. Microbac Laboratories, Inc. (US) |
14.2.7. Almac Group (UK) |
14.2.8. North American Science Associates, Inc. (US) |
14.2.9. Toxikon (US) |
14.2.10. Pacific Biolabs (US) |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players